Subscribe To Our Free Newsletter |
Dr Reddy’s Q2 net up 26% at Rs 722 cr
Higher sales growth and sustained product margins from the company's US generics business led to the good numbers
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!